Sildenafil Actavis

Country: Kesatuan Eropah

Bahasa: Inggeris

Sumber: EMA (European Medicines Agency)

Beli sekarang

Risalah maklumat Risalah maklumat (PIL)
13-11-2023
Ciri produk Ciri produk (SPC)
13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam (PAR)
11-05-2015

Bahan aktif:

sildenafil

Boleh didapati daripada:

Actavis Group PTC ehf

Kod ATC:

G04BE03

INN (Nama Antarabangsa):

sildenafil

Kumpulan terapeutik:

Urologicals

Kawasan terapeutik:

Erectile Dysfunction

Tanda-tanda terapeutik:

Treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.In order for Sildenafil Actavis to be effective, sexual stimulation is required.

Ringkasan produk:

Revision: 17

Status kebenaran:

Authorised

Tarikh kebenaran:

2009-12-10

Risalah maklumat

                                30
B. PACKAGE LEAFLET
31
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
SILDENAFIL ACTVIS 25 MG, 50 MG AND 100 MG FILM-COATED TABLETS
SILDENAFIL ACTAVIS 25 MG FILM-COATED TABLETS
SILDENAFIL ACTAVIS 50 MG FILM-COATED TABLETS
SILDENAFIL ACTAVIS 100 MG FILM-COATED TABLETS
sildenafil
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
nurse.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor, pharmacist or
nurse.This includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Sildenafil Actavis is and what it is used for
2.
What you need to know before you take Sildenafil Actavis
3.
How to take Sildenafil Actavis
4.
Possible side effects
5.
How to store Sildenafil Actavis
6.
Contents of the pack and other information
1.
WHAT SILDENAFIL ACTAVIS IS AND WHAT IT IS USED FOR
Sildenafil Actavis contains the active substance sildenafil which
belongs to a group of medicines
called phosphodiesterase type 5 (PDE5) inhibitors. It works by helping
to relax the blood vessels in
your penis, allowing blood to flow into your penis when you get
sexually excited. Sildenafil Actavis
will only help you to get an erection if you are sexually stimulated.
Sildenafil Actavis is a treatment for adult men with erectile
dysfunction, sometimes known as
impotence. This is when a man cannot get, or keep a hard, erect penis
suitable for sexual activity.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE SILDENAFIL ACTAVIS
DO NOT TAKE SILDENAFIL ACTAVIS
-
If you are allergic to sildenafil or any of the other ingredients of
this medicine (listed in section
6).
-
If you are taking medicines called nitrates, as the combination may
lead to a dangerous fall in
your blood pressure
                                
                                Baca dokumen lengkap
                                
                            

Ciri produk

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Sildenafil Actavis 25 mg film-coated tablets
Sildenafil Actavis 50 mg film-coated tablets
Sildenafil Actavis 100 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains sildenafil citrate equivalent to 25, 50 or 100 mg
of sildenafil.
Excipient with known effect
Sildenafil Actavis 25 mg tablets
Each tablet contains 62.38 mg lactose (as monohydrate).
Sildenafil Actavis 50 mg tablets
Each tablet contains 124.76 mg lactose (as monohydrate).
Sildenafil Actavis 100 mg tablets
Each tablet contains 249.52 mg lactose (as monohydrate).
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet.
Sildenafil Actavis 25 mg film-coated tablets
Sildenafil Actavis 25 mg film-coated tablets are blue elliptical,
biconvex, 10.0 x 5.0 mm and marked
“SL25” on one side.
Sildenafil Actavis 50 mg film-coated tablets
Sildenafil Actavis 50 mg film-coated tablets are blue elliptical,
biconvex, 13.0 x 6.5 mm and marked
“SL50” on one side.
Sildenafil Actavis 100 mg film-coated tablets
Sildenafil Actavis 100 mg film-coated tablets are blue elliptical,
biconvex, 17.0 x 8.5 mm and marked
“SL100” on one side.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Sildenafil Actavis is indicated in adult men with erectile
dysfunction, which is the inability to achieve
or maintain a penile erection sufficient for satisfactory sexual
performance.
In order for Sildenafil Actavis to be effective, sexual stimulation is
required.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Use in adults _
The recommended dose is 50 mg taken as needed approximately one hour
before sexual activity.
3
Based on efficacy and tolerability, the dose may be increased to 100
mg or decreased to 25 mg. The
maximum recommended dose is 100 mg. The maximum recommended dosing
frequency is once per
day. If Sildenafil Actavis is taken with food, the onset of activity
may be delayed compared to the
fasted state (see section 5.2)
                                
                                Baca dokumen lengkap
                                
                            

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Bulgaria 13-11-2023
Ciri produk Ciri produk Bulgaria 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Bulgaria 11-05-2015
Risalah maklumat Risalah maklumat Sepanyol 13-11-2023
Ciri produk Ciri produk Sepanyol 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Sepanyol 11-05-2015
Risalah maklumat Risalah maklumat Czech 13-11-2023
Ciri produk Ciri produk Czech 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Czech 11-05-2015
Risalah maklumat Risalah maklumat Denmark 13-11-2023
Ciri produk Ciri produk Denmark 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Denmark 11-05-2015
Risalah maklumat Risalah maklumat Jerman 13-11-2023
Ciri produk Ciri produk Jerman 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Jerman 11-05-2015
Risalah maklumat Risalah maklumat Estonia 13-11-2023
Ciri produk Ciri produk Estonia 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Estonia 11-05-2015
Risalah maklumat Risalah maklumat Greek 13-11-2023
Ciri produk Ciri produk Greek 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Greek 11-05-2015
Risalah maklumat Risalah maklumat Perancis 13-11-2023
Ciri produk Ciri produk Perancis 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Perancis 11-05-2015
Risalah maklumat Risalah maklumat Itali 13-11-2023
Ciri produk Ciri produk Itali 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Itali 11-05-2015
Risalah maklumat Risalah maklumat Latvia 13-11-2023
Ciri produk Ciri produk Latvia 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Latvia 11-05-2015
Risalah maklumat Risalah maklumat Lithuania 13-11-2023
Ciri produk Ciri produk Lithuania 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Lithuania 11-05-2015
Risalah maklumat Risalah maklumat Hungary 13-11-2023
Ciri produk Ciri produk Hungary 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Hungary 11-05-2015
Risalah maklumat Risalah maklumat Malta 13-11-2023
Ciri produk Ciri produk Malta 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Malta 11-05-2015
Risalah maklumat Risalah maklumat Belanda 13-11-2023
Ciri produk Ciri produk Belanda 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Belanda 11-05-2015
Risalah maklumat Risalah maklumat Poland 13-11-2023
Ciri produk Ciri produk Poland 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Poland 11-05-2015
Risalah maklumat Risalah maklumat Portugis 13-11-2023
Ciri produk Ciri produk Portugis 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Portugis 11-05-2015
Risalah maklumat Risalah maklumat Romania 13-11-2023
Ciri produk Ciri produk Romania 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Romania 11-05-2015
Risalah maklumat Risalah maklumat Slovak 13-11-2023
Ciri produk Ciri produk Slovak 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Slovak 11-05-2015
Risalah maklumat Risalah maklumat Slovenia 13-11-2023
Ciri produk Ciri produk Slovenia 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Slovenia 11-05-2015
Risalah maklumat Risalah maklumat Finland 13-11-2023
Ciri produk Ciri produk Finland 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Finland 11-05-2015
Risalah maklumat Risalah maklumat Sweden 13-11-2023
Ciri produk Ciri produk Sweden 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Sweden 11-05-2015
Risalah maklumat Risalah maklumat Norway 13-11-2023
Ciri produk Ciri produk Norway 13-11-2023
Risalah maklumat Risalah maklumat Iceland 13-11-2023
Ciri produk Ciri produk Iceland 13-11-2023
Risalah maklumat Risalah maklumat Croat 13-11-2023
Ciri produk Ciri produk Croat 13-11-2023
Laporan Penilaian Awam Laporan Penilaian Awam Croat 11-05-2015

Cari amaran yang berkaitan dengan produk ini